Hims & Hers Health (HIMS) Competitors $33.06 -1.98 (-5.65%) As of 03:59 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock HIMS vs. NTRA, FMS, GH, OPCH, RDNT, SHC, WGS, BTSG, PRVA, and SGRYShould you be buying Hims & Hers Health stock or one of its competitors? The main competitors of Hims & Hers Health include Natera (NTRA), Fresenius Medical Care (FMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), GeneDx (WGS), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Hims & Hers Health vs. Natera Fresenius Medical Care Guardant Health Option Care Health RadNet Sotera Health GeneDx BrightSpring Health Services Privia Health Group Surgery Partners Hims & Hers Health (NYSE:HIMS) and Natera (NASDAQ:NTRA) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their media sentiment, analyst recommendations, profitability, earnings, dividends, valuation, risk, institutional ownership and community ranking. Which has more volatility and risk, HIMS or NTRA? Hims & Hers Health has a beta of 1.65, meaning that its share price is 65% more volatile than the S&P 500. Comparatively, Natera has a beta of 1.8, meaning that its share price is 80% more volatile than the S&P 500. Which has stronger valuation & earnings, HIMS or NTRA? Hims & Hers Health has higher earnings, but lower revenue than Natera. Natera is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B5.28-$23.55M$0.5464.96Natera$1.70B12.34-$434.80M-$1.53-101.24 Do institutionals and insiders believe in HIMS or NTRA? 63.5% of Hims & Hers Health shares are owned by institutional investors. Comparatively, 99.9% of Natera shares are owned by institutional investors. 17.7% of Hims & Hers Health shares are owned by company insiders. Comparatively, 7.6% of Natera shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. Does the media prefer HIMS or NTRA? In the previous week, Hims & Hers Health had 8 more articles in the media than Natera. MarketBeat recorded 35 mentions for Hims & Hers Health and 27 mentions for Natera. Natera's average media sentiment score of 1.38 beat Hims & Hers Health's score of 0.68 indicating that Natera is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 17 Very Positive mention(s) 5 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Natera 23 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts recommend HIMS or NTRA? Hims & Hers Health currently has a consensus price target of $36.92, suggesting a potential upside of 5.24%. Natera has a consensus price target of $175.76, suggesting a potential upside of 13.48%. Given Natera's stronger consensus rating and higher possible upside, analysts plainly believe Natera is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 2 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.08Natera 0 Sell rating(s) 0 Hold rating(s) 16 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is HIMS or NTRA more profitable? Hims & Hers Health has a net margin of 8.19% compared to Natera's net margin of -14.01%. Hims & Hers Health's return on equity of 10.97% beat Natera's return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% Natera -14.01%-26.23%-14.27% Does the MarketBeat Community favor HIMS or NTRA? Natera received 448 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.96% of users gave Natera an outperform vote while only 35.25% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes4335.25% Underperform Votes7964.75% NateraOutperform Votes49168.96% Underperform Votes22131.04% SummaryNatera beats Hims & Hers Health on 10 of the 18 factors compared between the two stocks. Get Hims & Hers Health News Delivered to You Automatically Sign up to receive the latest news and ratings for HIMS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HIMS vs. The Competition Export to ExcelMetricHims & Hers HealthOffices & clinics of medical doctors IndustryMedical SectorNYSE ExchangeMarket Cap$7.79B$1.19B$5.52B$18.91BDividend YieldN/AN/A5.11%4.04%P/E Ratio79.7319.7022.4532.79Price / Sales5.281.25393.5128.87Price / CashN/A36.0138.1817.53Price / Book21.7912.166.754.48Net Income-$23.55M-$52.07M$3.22B$1.02B7 Day Performance31.14%18.16%2.40%2.60%1 Month Performance20.53%30.79%-0.84%-2.55%1 Year Performance180.19%16.04%17.85%5.89% Hims & Hers Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HIMSHims & Hers Health3.1835 of 5 stars$33.06-5.7%$36.92+11.7%+179.6%$7.34B$1.48B75.14650Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageGap DownHigh Trading VolumeNTRANatera2.8937 of 5 stars$151.60-1.4%$175.76+15.9%+64.7%$20.45B$1.70B-85.943,020Positive NewsGap DownFMSFresenius Medical Care3.7946 of 5 stars$24.94+2.0%$25.30+1.4%+20.6%$14.63B$19.34B20.60123,200Upcoming EarningsPositive NewsGHGuardant Health3.9413 of 5 stars$47.47-1.7%$49.00+3.2%+172.3%$5.86B$739.02M-13.341,790Earnings ReportNews CoverageGap DownOPCHOption Care Health3.1485 of 5 stars$32.97+0.2%$33.75+2.4%+1.5%$5.41B$5.00B27.705,600Earnings ReportAnalyst UpgradeNews CoveragePositive NewsRDNTRadNet4.0186 of 5 stars$50.23-0.1%$69.75+38.9%+6.3%$3.71B$1.83B-715.688,970Positive NewsGap DownSHCSotera Health2.3825 of 5 stars$11.23+0.6%$15.20+35.4%-0.6%$3.18B$1.10B44.853,000Upcoming EarningsWGSGeneDx2.2072 of 5 stars$110.72-0.3%$72.33-34.7%+963.4%$3.11B$305.45M-56.491,200News CoveragePositive NewsGap DownBTSGBrightSpring Health Services2.5411 of 5 stars$17.06+0.8%$21.67+27.0%+60.7%$2.99B$11.27B-65.6035,000Upcoming EarningsNews CoveragePositive NewsPRVAPrivia Health Group4.1192 of 5 stars$23.09-0.4%$27.14+17.6%+25.5%$2.80B$1.74B230.97810Analyst ForecastShort Interest ↓News CoveragePositive NewsSGRYSurgery Partners3.1731 of 5 stars$21.47-0.1%$34.75+61.9%-9.8%$2.74B$3.11B-44.6912,200Upcoming EarningsPositive News Related Companies and Tools Related Companies NTRA Competitors FMS Competitors GH Competitors OPCH Competitors RDNT Competitors SHC Competitors WGS Competitors BTSG Competitors PRVA Competitors SGRY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:HIMS) was last updated on 4/30/2025 by MarketBeat.com Staff From Our Partners"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredIf you missed your chance with Tesla...Elon Musk is moments from launching a revolutionary technology some Silicon Valley insiders are calling "The F...Brownstone Research | SponsoredMassive new energy source found in UtahNEW THIS WEEK: Huge Energy Discovery In Utah The Department of Energy say it could power America for millio...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hims & Hers Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Hims & Hers Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy HIMS Stock Free HIMS Stock Alerts